EENT · PANCE / PANRE

Age-Related Cataracts

Progressive opacification of the crystalline lens — leading global cause of reversible blindness; surgery is curative.

Also known as: age-related cataract, senile cataract, nuclear sclerotic cataract, cortical cataract, posterior subcapsular cataract

Overview

Opacification of the crystalline lens that scatters light and reduces visual acuity. Age-related (senile) cataracts are the most common form and are classified morphologically as nuclear sclerotic, cortical, or posterior subcapsular (PSC); many patients have mixed types.

Epidemiology

Leading cause of reversible blindness worldwide and the most common cause of preventable blindness. By age 80, more than half of US adults have significant cataract or have undergone cataract surgery. Cataract surgery is the most commonly performed operation in the US.

🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Age-Related Cataracts outline — plus all 514 diagnoses, 3,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Age >60 (most important)
  • Cigarette smoking
  • Diabetes mellitus
  • Chronic corticosteroid use (topical, inhaled, or systemic) — PSC
  • Chronic UV-B light exposure
  • Trauma (traumatic cataract — often rosette pattern)
  • Intraocular inflammation (uveitis), prior intraocular surgery
  • Ionizing radiation
  • Hypocalcemia, Wilson disease, myotonic dystrophy, atopic dermatitis
  • Genetic / congenital (rubella, galactosemia in pediatric)

Pathophysiology

Oxidative stress, protein cross-linking, and altered lens fiber organization disrupt the transparency of the crystalline lens. Nuclear sclerosis causes hardening and yellow/brown discoloration of the central lens (myopic shift). Cortical opacities are wedge-shaped (spoke-like) in the periphery and cause glare. Posterior subcapsular cataracts develop just anterior to the posterior capsule and disproportionately impair near vision and vision in bright light.

Clinical presentation

Symptoms

  • Gradual painless decrease in vision over months to years
  • Glare and halos around lights, especially at night
  • Difficulty with night driving (oncoming headlights)
  • Decreased contrast sensitivity, faded colors
  • Frequent prescription changes; 'second sight' (near vision temporarily improves with myopic shift from nuclear sclerosis)
  • PSC: prominent glare and poor near vision in bright light

Signs / physical exam

  • Decreased visual acuity not improved with refraction beyond a point
  • Diminished red reflex on direct ophthalmoscopy
  • Lens opacity on slit-lamp examination (graded as 1-4+ by LOCS system)
  • Brunescence of nucleus in advanced nuclear sclerosis
  • Cortical spokes peripherally
  • Posterior subcapsular plaque just anterior to posterior capsule

Classic findings

Painless gradual vision loss, glare, and diminished red reflex in an older patient.

Differential diagnosis

  • Refractive error — Improves with refraction; clear lens
  • Age-related macular degeneration — Central distortion (metamorphopsia), drusen on exam; cataract surgery may not restore central acuity
  • Open-angle glaucoma — Painless peripheral field loss; cupped disc; IOP may be elevated
  • Diabetic retinopathy — Macular edema, hemorrhages on exam; A1c known
  • Corneal dystrophies / scarring — Slit-lamp shows corneal opacity; topography
  • Vitreous opacities / floaters — B-scan or dilated exam; transient symptoms

Diagnostic workup

Labs

  • Preoperative labs only as indicated by comorbidities (often none required for routine local-anesthesia cataract surgery)

Imaging

  • Visual acuity, contrast sensitivity, and glare testing
  • Slit-lamp examination after dilation
  • Dilated fundus examination (often easier after surgery if dense lens)
  • B-scan ultrasound if fundus cannot be visualized — rules out posterior pathology (retinal detachment, mass)
  • Biometry (IOL Master, immersion ultrasound) for IOL power calculation before surgery
  • Macular OCT if any suspicion of coexisting AMD or macular pathology

Diagnostic algorithm

TypeLocationVisual ImpactStrongest Association
Nuclear scleroticCentral nucleusDistance vision loss, myopic shift, color desaturationAging, smoking
CorticalPeripheral cortex (spokes)Glare, halos; central acuity often preserved earlyAging, UV exposure, diabetes
Posterior subcapsular (PSC)Just anterior to posterior capsuleNear vision and bright-light glareCorticosteroids, diabetes, radiation, trauma
Morphologic types of age-related cataract and their characteristic features.

Treatment

First-line

  • Refractive correction with updated glasses — sufficient if vision impact mild
  • Maximize lighting and contrast; reduce glare (anti-reflective lenses, brimmed hats, sunglasses)
  • Smoking cessation; control diabetes; minimize unnecessary systemic/inhaled corticosteroids
  • UV protection with sunglasses to slow progression

Second-line / adjunct

  • Cataract surgery — phacoemulsification with intraocular lens (IOL) implantation — indicated when cataract causes visual impairment that interferes with daily activities or driving, regardless of Snellen acuity; outpatient under topical/local anesthesia
  • IOL options: monofocal (most common), toric (corrects astigmatism), multifocal/EDOF (presbyopia correction at cost of nighttime glare/halos)
  • Femtosecond laser-assisted cataract surgery — alternative technique; no clear superiority for visual outcomes
  • Combined surgery with MIGS in patients with coexisting glaucoma
  • Postoperative topical antibiotic + topical steroid + NSAID for 2-4 weeks

Complications

  • Untreated: progressive vision loss, falls, motor vehicle accidents, loss of independence; rarely phacomorphic or phacolytic glaucoma in advanced cases
  • Surgical complications: posterior capsular rupture with vitreous loss, retained lens fragments, endophthalmitis (rare, sight-threatening), cystoid macular edema (Irvine-Gass), increased IOP, retinal detachment, corneal edema
  • Posterior capsular opacification ('after-cataract') in 20-40% — treated with YAG laser capsulotomy
  • Endophthalmitis 0.05-0.2% — vision-threatening; managed per EVS

PANCE pearls

  • Visual impact, not Snellen acuity alone, drives the decision for cataract surgery — glare disability and reading difficulty matter.
  • Nuclear sclerosis classically produces a myopic shift ('second sight'); cortical cataracts cause prominent glare; posterior subcapsular cataracts disproportionately worsen near vision and bright-light vision and are associated with steroids and diabetes.
  • A diminished red reflex in any age is abnormal — in children, leukocoria warrants urgent evaluation for retinoblastoma.
  • Coexisting macular disease (AMD, diabetic macular edema) limits the visual gain from cataract surgery — counsel patients about realistic expectations.
  • Endophthalmitis after cataract surgery is rare but vision-threatening; the Endophthalmitis Vitrectomy Study (EVS) guides vitreous tap + intravitreal antibiotics ± vitrectomy.

References

  • AAO 2021 — American Academy of Ophthalmology. Cataract in the Adult Eye Preferred Practice Pattern. Ophthalmology 2022;129(1):P1-P126
  • EVS — Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study. Arch Ophthalmol 1995;113(12):1479-1496
  • AREDS Report 9 — Age-Related Eye Disease Study Research Group. Risk factors associated with age-related nuclear and cortical cataract. Ophthalmology 2001;108(8):1400-1408

Practice EENT questions on FirstPassPA

Turn this outline into retention. 3,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Start studying free → Browse all 514 diagnoses

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants.